Pfizer Looking for Guinea Pigs to Trial New mRNA FLU Vaccine, Any Takers?

By Investment Watch Blog

Detailed Description:
This is a Phase 3, randomized, observer-blinded study to evaluate the efficacy, safety, tolerability, and immunogenicity of a quadrivalent influenza modRNA vaccine (qIRV) encoding HA of 4 seasonally recommended strains (2 A strains and 2 B strains) compared to licensed quadrivalent influenza vaccine (QIV) in healthy adults 18 years of age and older.
Participants may be enrolled in either the reactogenicity subset, immunogenicity subset, or both subsets. Efficacy will be assessed in this study through surveillance for influenza-like illness.

Original Source: